|
Real-time Estimate
Cboe BZX
02:19:17 2026-08-25 pm EDT
|
5-day change | 1st Jan Change | ||
| 66.08 USD | +1.55% |
|
-1.19% | +11.37% |
| Aug. 19 | RTW Biotech Opportunities get 0.2% uplift from Alesta deal | AN |
| Aug. 19 | RTW Biotech's Portfolio Company Alesta Therapeutics Signs Contract for Up to $490 Million Takeover | MT |
| Market Cap | 12.6B 10.79B 10.11B 9.24B 17.43B 1,201B 17.61B 119B 46.44B 606B 47.29B 46.26B 2,006B | P/E 2026 * |
22.3x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 14.67B 12.57B 11.78B 10.76B 20.31B 1,399B 20.51B 139B 54.09B 706B 55.09B 53.89B 2,337B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.12x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | +1.66% | ||
| 1 week | -1.31% | ||
| Current month | +10.15% | ||
| 1 month | +9.69% | ||
| 3 months | +25.02% | ||
| 6 months | +7.60% | ||
| Current year | +11.24% |
| 1 week | 64.71 |  | 69.62 |
| 1 month | 58.89 | | 70.98 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/2/26 | Free | Director | 7,490 | 0.0039% | ||
| 3/16/26 | Free | Chief Technology Officer | 66,379 | 0.0346% | ||
| 2/26/26 | Sell | Chief Technology Officer | 6,326 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | -1.31% | +13.01% | -29.40% | 12.6B | |
| +0.99% | +3.19% | +46.07% | +0.69% | 82.73B | |
| +2.68% | +29.00% | -19.83% | -34.19% | 57.94B | |
| +14.08% | +149.83% | +520.50% | +40.53% | 55.45B | |
| +0.76% | +2.39% | +0.08% | +35.11% | 52.57B | |
| +1.86% | +3.13% | +11.49% | +174.36% | 48.94B | |
| +1.91% | +4.51% | +62.90% | -15.99% | 32.23B | |
| +1.93% | +5.74% | +54.03% | +104.45% | 25.94B | |
| +0.60% | +4.98% | +0.65% | +188.89% | 22.1B | |
| +3.89% | +1.08% | +61.82% | +112.10% | 16.55B | |
| Average | +3.02% | +15.73% | +75.07% | +57.65% | 40.7B | |
| Weighted average by Cap. | +3.32% | +21.23% | +90.21% | +45.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.91B 3.35B 3.14B 2.86B 5.41B 372B 5.46B 36.99B 14.4B 188B 14.67B 14.35B 622B | 4.45B 3.82B 3.58B 3.27B 6.16B 425B 6.22B 42.17B 16.42B 214B 16.72B 16.36B 709B |
| Net income | 569M 488M 457M 418M 788M 54.28B 796M 5.39B 2.1B 27.38B 2.14B 2.09B 90.69B | 914M 783M 733M 670M 1.26B 87.09B 1.28B 8.65B 3.37B 43.94B 3.43B 3.36B 146B |
| Net Debt | 2.07B 1.78B 1.67B 1.52B 2.87B 198B 2.9B 19.65B 7.65B 99.8B 7.79B 7.62B 330B | 1.32B 1.13B 1.06B 965M 1.82B 125B 1.84B 12.46B 4.85B 63.28B 4.94B 4.83B 210B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-25 | $66.15 | +1.65% | 480,631 |
| 26-08-24 | $65.07 | -2.44% | 2,264,555 |
| 26-08-21 | $66.70 | -1.45% | 1,593,613 |
| 26-08-20 | $67.68 | -2.38% | 1,275,619 |
| 26-08-19 | $69.33 | +3.49% | 1,977,464 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
